Infection of placental trophoblasts by Toxoplasma gondii

Journal of Infectious Diseases

Volumn 188, Issue 4, 2003, Pages 608-616

  Abbasi, Marjan ^a   Kowalewska Grochowska, Kinga ^a,b   Bahar, Mohammad A ^c   Kilani, Ruhangiz T ^a   Winkler Lowen, Bonnie ^a   Guilbert, Larry J ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTRAUTERINE INFECTION; NONHUMAN; PARACRINE SIGNALING; PLACENTA DISORDER; PRIORITY JOURNAL; TOXOPLASMA GONDII; TROPHOBLAST; VERO CELL; VIRULENCE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; FEMALE; HUMANS; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL; TROPHOBLASTS; VERO CELLS;

EID: 0041941344     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/377132     Document Type: Article

References (55)

1. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 5th ed. Toronto: WB Saunders, 2001:205-346.
2. Wong SY, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis 1994; 18:853-61.
3. Stray-Pedersen B. Toxoplasmosis in pregnancy. Baillieres Clin Obstet Gynaecol 1993; 7:107-37.
4. Sever JL, Ellenberg JH, Ley AC, et al. Toxoplasmosis: maternal and pediatric findings in 23,000 pregnancies. Pediatrics 1988; 82:181-92.
5. Desmonts G, Couvreur J. Congenital toxoplasmosis: a prospective study of 378 pregnancies. N Engl J Med 1974; 290:1110-6.
6. Gilbert RE, Gras L, Wallon M, Peyron F, Ades AE, Dunn DT. Effect of prenatal treatment on mother to child transmission of Toxoplasma gondii: retrospective cohort study of 554 mother-child pairs in Lyon, France. Int J Epidemiol 2001; 30:1303-8.
7. Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis 2002; 186:684-9.
8. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410-5.
9. Gratzl R, Sodeck G, Platzer P, et al. Treatment of toxoplasmosis in pregnancy: concentrations of spiramycin and neospiramycin in maternal serum and amniotic fluid. Eur J Clin Microbiol Infect Dis 2002; 21:124-6.
10. Biedermann K, Flepp M, Fierz W, Joller-Jemelka H, Kleihues P. Pregnancy, immunosuppression and reactivation of latent toxoplasmosis. J Perinat Med 1995;23:191-203.
11. Benirschke K, Kaufmann P. Pathology of the human placenta. 4th ed. New York: Springer-Verlag, 2000.
12. Joshi W. Handbook of placental pathology. New York: Igaku-Shoin, 1994.
13. Fox H. The placenta and infection. In: Redman CW, Sargent I, Starkey PM, eds. The human placenta. Oxford: Blackwell Scientific, 1993: 313-33.
14. Ferro EA, Bevilacqua E, Favoreto-Junior S, Silva DA, Mortara RA, Mineo JR. Calomys callosus (Rodentia: Cricetidae) trophoblast cells as host cells to Toxoplasma gondii in early pregnancy. Parasitol Res 1999; 85:647-54.
15. Yui J, Garcia-Lloret MI, Brown AJ, et al. Functional, long-term cultures of human term trophoblasts purified by column-elimination of CD9 expressing cells. Placenta 1994; 15:231-46.
16. Kilani R, Chang L-J, Hemmings D, Guilbert LJ. Placental trophoblasts resist infection by multiple HIV-1 variants even with CMV co-infection but support HIV replication after provirus transfection. J Virol 1997;71: 6359-72.
17. Guilbert LJ, Winkler-Lowen B, Sherburne R, Rote NS, Li H, Morrish DW. Preparation and functional characterization of villous cytotrophoblasts free of syncytial fragments. Placenta 2002; 23:175-83.
18. Morrish DW, Dakour J, Li H, et al. In vitro cultured human term cytotrophoblast: a model for normal primary epithelial cells demonstrating a spontaneous differentiation programme that requires EGF for extensive development of syncytium. Placenta 1997; 18:577-85.
19. Hemmings DG, Kilani R, Nykiforuk C, Preiksaitis JK, Guilbert LJ. Permissive cytomegalovirus infection of primary villous term and first trimester trophoblasts. J Virol 1998; 72:4970-9.
20. Garcia-Lloret M, Yui J, Winkler-Lowen B, Guilbert LJ. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 1996; 167:324-32.
21. Douglas GC, King BF. Differentiation of human trophoblast cells in vitro as revealed by immunocytochemical staining of desmoplakin and nuclei. J Cell Sci 1990;96:131-41.
22. Yasumura Y, Kawakita M. The search for SV40 by means of tissue culture methods. Nippon Rinsho 1963;21:1201-19.
23. Nagineni CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun 1996; 64:4188-96.
24. Borel E, Mayencon M, Kaiser K, Picot S, Peyron F. Fluorogenic detection of viable Toxoplasma gondii. Parasite 1998;5:371-3.
25. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119:493-501.
26. Payne SG, Brindley DN, Guilbert LJ. Epidermal growth factor inhibits ceramide-induced apoptosis and lowers ceramide levels in primary placental trophoblasts. J Cell Physiol 1999; 180:263-70.
27. Branch DR, Shah A, Guilbert LJ. A specific and reliable bioassay for the detection of femtomolar levels of human and murine tumor necrosis factors. J Immunol Methods 1991; 143:251-61.
28. Mineo JR, McLeod R, Mack D, et al. Antibodies to Toxoplasma gondii major surface protein (SAG-1, P30) inhibit infection of host cells and are produced in murine intestine after peroral infection. J Immunol 1993; 150:3951-64.
29. Carruthers VB, Hakansson S, Giddings OK, Sibley LD. Toxoplasma gondii uses sulfated proteoglycans for substrate and host cell attachment. Infect Immun 2000; 68:4005-11.
30. Nash PB, Purner MB, Leon RP, Clarke P, Duke RC, Curiel TJ. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis. J Immunol 1998; 160:1824-30.
31. Carruthers VB. Host cell invasion by the opportunistic pathogen Toxoplasma gondii. Acta Trop 2002; 81:111-22.
32. Lindsay DS, Speer CA, Toivio-Kinnucan MA, Dubey JP, Blagburn BL. Use of infected cultured cells to compare ultrastructural features of Neospora caninum from dogs and Toxoplasma gondii. Am J Vet Res 1993; 54:103-6.
33. Chan G, Hemmings DG, Yurochko AD, Guilbert LJ. Human cytomegalovirus-caused damage to placental trophoblasts mediated by immediate-early gene-induced tumor necrosis factor-alpha. Am J Pathol 2002; 161:1371-81.
34. Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol 2000; 30:1217-58.
35. Arsenijevic D, Onuma H, Pecqueur C, et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000; 26:435-9.
36. Murray HW, Cohn ZA. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med 1980; 152:1596-609.
37. Adams LB, Hibbs JB Jr, Taintor RR, Krahenbuhl JL. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii: role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol 1990; 144:2725-9.
38. Alexander J, Scharton-Kersten TM, Yap G, Roberts CW, Liew FY, Sher A. Mechanisms of innate resistance to Toxoplasma gondii infection. Philos Trans R Soc Lond B Biol Sci 1997; 352:1355-9.
39. Smith SC, Guilbert LJ, Yui J, Baker PN, Davidge ST. The role of reactive nitrogen/oxygen intermediates in cytokine-induced trophoblast apoptosis. Placenta 1999;20:309-15.
40. Kudo Y, Boyd CA. The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants. J Physiol 2001;531:417-23.
41. Dimier IH, Bout DT. Inhibition of Toxoplasma gondii replication in IFN-gamma - activated human intestinal epithelial cells. Immunol Cell Biol 1997; 75:511-4.
42. + T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996; 157:798-805.
43. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-alpha and gamma- interferon against primary human placental trophoblasts. Placenta 1994; 15:819-35.
44. Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991; 139:327-35.
45. Gruss HJ. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily. Int J Clin Lab Res 1996; 26: 143-59.
46. Hu MS, Schwartzman JD, Yeaman GR, et al. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun 1999; 67:928-35.
47. Huppertz B, Frank HG, Reister F, Kingdom J, Korr H, Kaufmann P. Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro. Lab Invest 1999; 79:1687-702.
48. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001; 184:1249-50.
49. Smith SC, Symonds EM, Baker PN. Increased placental apoptosis in intrauterine growth restriction. Am J Obstet Gynecol 1997; 177:1395-401.
50. Salafia CM, Vintzileos AM, Silberman L, Bantham KF, Vogel CA. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992; 9:179-84.
51. Salafia CM, Minior VK, Pezzullo JC, Popek EJ, Rosenkrantz TS, Vintzileos AM. Intrauterine growth restriction in infants of less than thirty-two weeks' gestation: associated placental pathologic features. Am J Obstet Gynecol 1995; 173:1049-57.
52. Salafia CM, Pezzullo JC, Ghidini A, Lopez-Zeno JA, Whittington SS. Clinical correlations of patterns of placental pathology in preterm preeclampsia. Placenta 1998; 19:67-72.
53. Fuentes I, Rubio JM, Ramirez C, Alvar J. Genotypic characterization of Toxoplasma gondii strains associated with human toxoplasmosis in Spain: direct analysis from clinical samples. J Clin Microbiol 2001; 39: 1566-70.
54. Costa JM, Darde ML, Assouline B, Vidaud M, Bretagne S. Microsatellite in the beta-tubulin gene of Toxoplasma gondii as a new genetic marker for use in direct screening of amniotic fluids. J Clin Microbiol 1997; 35:2542-5.
55. Innes EA. Toxoplasmosis: comparative species susceptibility and host immune response. Comp Immunol Microbiol Infect Dis 1997;20: 131-8.